Dimethyl Fumarate

CAS 624-49-7 26 FDA-DMF suppliersSmall Molecule

Overview

Dimethyl fumarate is an orally bioavailable small molecule with immunomodulatory properties. It is used primarily for the treatment of multiple sclerosis.

API suppliers (6)

Suppliers of Dimethyl Fumarate backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

  • TAPI NL BV2 active DMF
  • Dr. Reddy's Laboratories Ltd.India1 active DMF
  • Zydus Lifesciences LimitedIndia1 active DMF
  • Granules India LimitedIndia1 active DMF
  • Zhejiang Huahai Pharmaceutical Co., Ltd.China
  • Natco PharmaIndia

Therapeutic areas

NeurologyAutoimmune DiseasesMultiple Sclerosis

Related APIs

Aripiprazole
45 suppliers
Pregabalin
40 suppliers
Levetiracetam
37 suppliers
Lurasidone Hydrochloride
35 suppliers
Lamotrigine
33 suppliers
Lacosamide
33 suppliers
Quetiapine Fumarate
29 suppliers
Risperidone
27 suppliers

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.

Start free trialBook a demo